Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy (Q41867768)
Jump to navigation
Jump to search
scientific article published on 11 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy |
scientific article published on 11 December 2013 |
Statements
1 reference
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy (English)
1 reference
Sagar Lonial
1 reference
Kenneth C Anderson
1 reference
Pieter Sonneveld
1 reference
Paul G Richardson
1 reference
Robert Z Orlowski
1 reference
Edward A Stadtmauer
1 reference
James R Berenson
1 reference
Sundar Jagannath
1 reference
Dixie-Lee Esseltine
1 reference
Helgi van de Velde
1 reference
Allison Berger
1 reference
David I Lichter
1 reference
Deborah Ricci
1 reference
William Trepicchio
1 reference
Rachel Neuwirth
1 reference
Erik Koenig
1 reference
Alessandra Di Bacco
1 reference
George Mulligan
1 reference
Stephen J Blakemore
1 reference
Hugues Bernard
1 reference
Bin Li
1 reference
Nibedita Chattopadhyay
1 reference
Joseph B Bolen
1 reference
Andrew J Dorner
1 reference
Jesús F San Miguel
1 reference
Matthew Schu
1 reference
11 December 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference